Approval · Notice of Compliance 4309 · 1996
REACTINE: Notice of Compliance 4309
Issued July 11, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4309
- Date
- July 11, 1996
- Company
- Pfizer Canada Inc., Consumer Healthcare DivisionMarkham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Histamine h1 receptor antagonist
Products in this notice
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 5 MG per TAB
- CETIRIZINE HYDROCHLORIDE 10 MG per TAB